Basel Medical Group, a listed company, suspends the acquisition of BTC digital assets

On July 18, according to Globenewswire, Basel Medical Group (Nasdaq: BMGL) announced the suspension of its acquisition of $BTC digital assets. The decision was reached after full discussion with the Bitcoin Holders Alliance, mainly due to the regulatory review of digital assets by the U.S. authorities, and the possible impact of the current unclear policy direction on the transaction. Both parties believe that it is more prudent to postpone the transaction until the regulatory environment is clearer, and said that they will continue to closely monitor regulatory developments and re-evaluate the acquisition opportunity when the situation becomes clear. [TechFlow]